The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Does anyone have a forecast on what the financial result will be? Good, royalties pouring in? Bad, jam tomorrow? Awful...?
Apart from Kyler increasing his holdings, news has been non existent this last 6 months.
+25% Is a good start 👌
No dramatic drop. A couple of percentage point this morning. A minor protest vote.
The BoD have now delivered everything, except to the initial schedule. We are now revenue positive with great assets. Dividends on the horizon.
Patience pays.
I have no idea either but it's still going...
I heard this differently: Eroxon® expected to gain around a 20% share of the clinically proven ED treatment market.
Watch the video again and tell me if I'm wrong please.. I heard and understood an incremental 20%. Read a new market on top of traditional ED. The cherry on the cake if you will.
Double bonus.
When you scale the launch success revenues from little Britain and Belgium to the huge markets that are planned @20% incremental to current ED market, this is phenomenal.
With incremental market development proven, there will be a bidding war to take this over.
Key takeaway from me..
- No dilution.
- License imminent.
Really positive message.
Demir continue to pump time and money into this.
Demir are not inexperienced fools, indeed they are extremely successful. That's what keeps me invested here.
Broker notes generally a thin on substance, thick on dreams. IMO.
Helloooo we're waaaaiiiitttiiiinnnnggg for the license for more than a year. All posted out till that happens.
Https://twitter.com/Heliumone1/status/1692437799796937101?t=ppsXcpDKeKFzK672DbGWzg&s=19
There is so much target fixation on the immediate share price its unhealthy.
Look up, it's happening!